Juan Dubrot

6PUBLICATIONS
69CO-AUTHORS
Molecular targetsCancer cell biologyChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2026
Complement-driven NETosis mediates immunotherapy resistance in STK11-mutant lung adenocarcinoma.

|Jun 29, 2026
Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

|Jun 09, 2026
Inflammatory cytokines induce new cancer dependencies.

|Sep 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target.

Cong Fu, Robert Saddawi-Konefka, Jordan M Chinai

|Dec 05, 2023
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.

Azucena Ramos, Catherine E Koch, Yunpeng Liu-Lupo

|Dec 01, 2021
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.

Meng-Ju Wu, Lei Shi, Juan Dubrot

Pageof 1

Frequent Collaborators

4 joint publications

Robert T Manguso

4 joint publications

Kathleen B Yates

3 joint publications

Audrey J Muscato

2 joint publications

Meng-Ju Wu